Evaluating the Immune Response for COVID-19

CompletedOBSERVATIONAL
Enrollment

214

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

February 2, 2022

Study Completion Date

February 2, 2022

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

COVID-19 RT-PCR

Nasoropharyngeal swabs for COVID-19 RT-PCR - initial screening/retest +every 10 days in 100 days followup period

DIAGNOSTIC_TEST

COVID-19 Serology

Blood samples for COVID-19 serology - initial screening/retest +every 10 days in 100 days followup period Each sample will be examined by 4-6 serology kits.

OTHER

Symptoms questionnare

Symptoms questionnaire which will be filled by participant on initial screening/retest visit + every 10 days in 100 days followup period

Trial Locations (1)

70300

Assaf-Harofeh Medical Center, Ramla

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT04348422 - Evaluating the Immune Response for COVID-19 | Biotech Hunter | Biotech Hunter